US pharma major Eli Lilly has revealed plans to build a new $3 billion manufacturing facility in Katwijk, the Netherlands, ...
UK biotech Slingshot Therapeutics, part of the Syncona Accelerator, has expanded its senior team with the appointments of John Isaac as chief scientific officer and Bobby Soni as chief business ...
The US Food and Drug Administration (FDA) has approved Belgium drugmaker UCB’s Kygevvi (doxecitine and doxribtimine) powder ...
US biopharma Vertex Pharmaceuticals has reported consolidated financial results for the third quarter of 2025 and refined its ...
US pharma giant Merck & Co, known as MSD outside of the USA and Canada, today announced that the company, through subsidiary ...
Swiss specialty drugmaker Santhera Pharmaceuticals saw its shares rise 5.8% to 10.90 francs today, after it reported positive ...
Tuesday is shaping up to be another dark day in the stock market for US genetic medicines company Sarepta Therapeutics as key ...
Sickle cell disease (SCD) is a group of inherited blood disorders characterised by a single point mutation in the β-globin ...
SOTIO Biotech, a Czech clinical-stage biopharma owned by PPF Group, today announced the promotion of Dr Vivi Boura, an ...
Canadian infection control company Ondine Biomedical (AIM: OBI) is expanding its Steriwave nasal photodisinfection platform ...
George Tidmarsh has resigned as director of the US Food and Drug Administration’s Center for Drug Evaluation and Research ...
The pharmaceutical industry is experiencing a seismic shift in regulatory transparency as the US Food and Drug Administration (FDA) implements its most ambitious disclosure initiative to date.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback